glp 1 for eating disorders GLP-1 Medications and Disorders: Risks, Benefits & Mental Health Support The rapid rise of GLP-1
Description
What doses are used for micro-dosing
Bosello S, De Santis M, Lama G, et al

Histology of the enterochromaffin cell system

At 20 mg/mL concentration: The higher concentration keeps all doses in single-injection territory but requires more precise measuring

Patients have to learn that, although GI AEs may occur, these will be transient and of mild/moderate severity in the majority of cases and that following specific dietary recommendations will relieve symptoms (Table 2, Figure 1, Figure 2 and Figure 3)

The upper arm The back of the upper arm works well but presents a practical challenge: most people cannot comfortably self-inject in that location
